9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor.

The concentration of type I interferon receptor (IFN-Rc) in the liver is a crucial factor in determining the efficacy of interferon (IFN) therapy in patients with chronic hepatitis C. Retinoic acids (RAs) can enhance the expression of type I IFN-Rc expression. The aim of this study was to investigate whether RAs increase the anti-hepatitis C virus (HCV) effect of IFN through an increase in IFN-Rc. The hepatocellular carcinoma cell line HuH-7 was treated with 10(-7) mol/L all-trans RA (ATRA) and 9-cis RA (9-CRA). Expression of type I IFN-Rc was investigated at both the mRNA and protein levels with the use of real-time quantitative polymerase chain reaction and flow cytometry, respectively. We investigated the anti-HCV effect, using in vitro HCV transfection, by monitoring the level of HCV RNA in the culture medium. ATRA and 9-CRA enhanced the expression of type I IFN-Rc at both the mRNA and protein levels. After IFN-alpha treatment, the activity of 2,5'-oligoadenylate synthetase was enhanced by RAs, and this enhancement was abolished when blocking antibodies had previously been bound to the surface receptors. IFN treatment decreased the concentration of HCV RNA, and this effect was enhanced by treatment with RAs. Our findings suggest that RAs enhance the anti-HCV replication effect of IFN-alpha through up-regulation of type I IFN-Rc in HuH-7 cells.

[1]  P. Couzigou,et al.  Combination of ribavirin and interferon‐alfa surpasses high doses of interferon‐alfa alone in patients with genotype‐1b–related chronic hepatitis C , 2000, Hepatology.

[2]  J. Tavernier,et al.  Dimerization of the Interferon Type I Receptor IFNaR2–2 Is Sufficient for Induction of Interferon Effector Genes but Not for Full Antiviral Activity* , 1999, The Journal of Biological Chemistry.

[3]  N. Bouck,et al.  Retinoic Acid and Interferon α Act Synergistically as Antiangiogenic and Antitumor Agents against Human Head and Neck Squamous Cell Carcinoma , 1998 .

[4]  M. Yanagi,et al.  Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients , 1998, Journal of medical virology.

[5]  J. Fahrenkrug,et al.  Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines. , 1998, Cancer research.

[6]  Y. Kaneita,et al.  Hepatitis C virus is frequently coinfected with serum marker‐negative hepatitis B virus: Probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection , 1997, Journal of medical virology.

[7]  N. Ishimura,et al.  Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. , 1997, Journal of hepatology.

[8]  T. Poynard,et al.  Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration , 1996, Hepatology.

[9]  E. Borden,et al.  Modulation of Interferon (IFN)-inducible Gene Expression by Retinoic Acid , 1996, The Journal of Biological Chemistry.

[10]  P. Chambon,et al.  Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors , 1995, Molecular and cellular biology.

[11]  B. Cohen,et al.  The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.

[12]  K. Chayama,et al.  Factors predictive of response to interferon‐α therapy in hepatitis C virus infection , 1994, Hepatology.

[13]  D. Rifkin,et al.  Mechanism of retinoid‐induced activation of latent transforming growth factor‐β in bovine endothelial cells , 1993, Journal of cellular physiology.

[14]  P. Chambon,et al.  All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs , 1992, Cell.

[15]  R. Nordan,et al.  Detection of functional interferon alpha receptors in human neuroendocrine tumor cell lines using a new monoclonal antibody. , 1992, European cytokine network.

[16]  G. Lutfalla,et al.  The structure of the human interferon alpha/beta receptor gene. , 1992, The Journal of biological chemistry.

[17]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[18]  M. Pfahl,et al.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.

[19]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[20]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[21]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[22]  A. Myc,et al.  Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes , 1991, The Journal of cell biology.

[23]  K. Umesono,et al.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.

[24]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.

[25]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.

[26]  P. Chambon,et al.  A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[28]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.

[29]  M. Sporn,et al.  Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. , 1989, Cell regulation.

[30]  K. Umesono,et al.  Determinants of target gene specificity for steroid/thyroid hormone receptors , 1989, Cell.

[31]  E. Schiff,et al.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. , 1989, The New England journal of medicine.

[32]  M. Pfahl,et al.  A new retinoic acid receptor identified from a hepatocellular carcinoma , 1988, Nature.

[33]  C. Marth,et al.  Effects of retinoids and interferon‐gamma on cultured breast cancer cells in comparison with tumor necrosis factor alpha , 1987, International journal of cancer.

[34]  F. Sarkar,et al.  Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells. , 1982, The Journal of biological chemistry.